Performance of BSX Boston Scientific | 38.3% in 12m
Compare BSX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Boston Scientific with its related Sector/Index XLV
Performance Duell BSX vs XLV
| TimeFrame | BSX | XLV |
|---|---|---|
| 1 Day | 1.14% | 0.25% |
| 1 Week | -0.44% | 0.62% |
| 1 Month | 6.93% | -2.22% |
| 3 Months | 13.2% | -0.46% |
| 6 Months | 38.7% | 11.43% |
| 12 Months | 38.3% | 7.26% |
| YTD | 26.0% | 1.84% |
| Rel. Perf. 1m | 0.85 | |
| Rel. Perf. 3m | 2.12 | |
| Rel. Perf. 6m | 2.20 | |
| Rel. Perf. 12m | 2.54 |
Is Boston Scientific a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Boston Scientific (NYSE:BSX) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.00 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BSX as of May 2024 is 72.83. This means that BSX is currently overvalued and has a potential downside of -0.03% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BSX as of May 2024 is 72.83. This means that BSX is currently overvalued and has a potential downside of -0.03% (Sold with Premium).
Is BSX a buy, sell or hold?
- Strong Buy: 21
- Buy: 8
- Hold: 3
- Sell: 1
- Strong Sell: 0
Values above 0%: BSX is performing better - Values below 0%: BSX is underperforming
Compare BSX with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.04% | 8.49% | 20.21% | 11.14% |
| US NASDAQ 100 | QQQ | -1.48% | 8.43% | 19.79% | 0.09% |
| US Dow Jones Industrial 30 | DIA | -1.61% | 8.03% | 24.06% | 20.26% |
| German DAX 40 | DBXD | 0.45% | 9.00% | 20.41% | 25.11% |
| UK FTSE 100 | ISFU | -2.10% | 3.72% | 24.31% | 28.81% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.95% | 3.30% | 35.47% | 48.04% |
| Hongkong Hang Seng | HSI | -6.20% | -1.13% | 39.88% | 52.13% |
| Japan Nikkei 225 | EXX7 | -2.79% | 11.74% | 25.06% | 17.85% |
| India NIFTY 50 | INDA | -1.22% | 4.90% | 19.25% | 9.15% |
| Brasil Bovespa | EWZ | -2.88% | 6.24% | 33.80% | 14.00% |
BSX Boston Scientific vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.56% | 10.07% | 19.34% | -0.01% |
| Consumer Discretionary | XLY | -1.58% | 8.07% | 27.20% | 14.94% |
| Consumer Staples | XLP | -0.82% | 5.12% | 26.65% | 36.38% |
| Energy | XLE | 2.87% | 11.60% | 29.99% | 17.01% |
| Financial | XLF | 0.22% | 9.57% | 17.59% | 9.12% |
| Health Care | XLV | -1.06% | 9.15% | 27.25% | 31.00% |
| Industrial | XLI | -0.53% | 8.75% | 16.81% | 12.31% |
| Materials | XLB | -0.45% | 10.54% | 23.84% | 22.38% |
| Real Estate | XLRE | -1.98% | 10.60% | 31.39% | 33.30% |
| Technology | XLK | -1.80% | 9.26% | 20.30% | 0.52% |
| Utilities | XLU | -3.79% | 1.85% | 26.13% | 34.30% |
| Aerospace & Defense | XAR | -2.92% | 5.28% | 23.11% | 14.80% |
| Biotech | XBI | -8.21% | 8.09% | 12.74% | 30.10% |
| Homebuilder | XHB | -1.89% | 10.07% | 2.34% | -11.75% |
| Retail | XRT | -0.71% | 9.65% | 19.63% | 14.80% |
Does Boston Scientific outperform its market, is BSX a Sector Leader?
Yes, over the last 12 months Boston Scientific (BSX) made 38.26%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.26%.
Over the last 3 months BSX made 13.17%, while XLV made -0.46%.
Yes, over the last 12 months Boston Scientific (BSX) made 38.26%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.26%.
Over the last 3 months BSX made 13.17%, while XLV made -0.46%.
| Period | BSX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 6.93% | -2.22% | -1.56% |
| 3 Months | 13.17% | -0.46% | 3.75% |
| 12 Months | 38.26% | 7.26% | 27.12% |